ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis "
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Elective Abdominal Aortic Aneurysm
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 306
- Locations
- 1
- Primary Endpoint
- Death and major adverse events
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter.
The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.
Detailed Description
ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5 cm in diameter. The aim of the study is to compare the mortality and the occurrence of severe general, vascular and local complications in two groups of patients treated by either by open surgery or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary endpoint are respectively the survival without severe complications and minor morbidity.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients aged 50 years old or more (more than 80 possible depending on physiological age)
- •Level 0, 1, or 2 of operative risk
- •Abdominal aortic aneurysm with a diameter \> or equal to 50 mm or \> or equal to 40 mm if rapid growing (10 mm or more in a year), or painful, or saccular aneurysms, or aneurisms of common iliac arteries with a diameter equal or superior to 30 mm; or women with a diameter equal to 45 mm;
- •Aortic neck superior or equal to 1.5 cm
- •No stenosis superior or equal to 75% of the superior mesenteric artery
- •Proximal neck angulation inferior to 80°
- •Diameter of the iliac arteries compatible with introducer sheath
- •Inform consent signed
Exclusion Criteria
- •Aneurysm involving the renal arteries or with the length of the neck less than 1.5 cm
- •Thrombus or major calcification in the neck
- •Diameter of the iliac arteries not compatible with introducer sheath
- •Level 3 of operative risk
- •History of major iodine allergy (Quincke oedema, anaphylactic shock)
- •Other comorbidity with life expectancy less than 6 months
- •Follow up impossible during the trial
- •Participation in another trial
- •Inform consent not signed
Outcomes
Primary Outcomes
Death and major adverse events
Time Frame: 4 years
Secondary Outcomes
- Minor adverse events (systemic vascular or non vascular complications)(4 years)